| The MEST score provides earlier risk prediction in lgA nephropathy SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ... Kidney international 89 (1), 167-175, 2016 | 266 | 2016 |
| Renal vascular resistance in essential hypertension: duplex-Doppler ultrasonographic evaluation K Galesic, B Brkljacic, M Sabljar-Matovinovic, J Morovic-Vergles Angiology 51 (8), 667, 2000 | 95 | 2000 |
| Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update R Coppo, G D'Arrigo, G Tripepi, ML Russo, ISD Roberts, S Bellur, ... Nephrology Dialysis Transplantation 35 (6), 1002-1009, 2020 | 84 | 2020 |
| Circulating bone morphogenetic protein 1–3 isoform increases renal fibrosis L Grgurevic, B Macek, DR Healy, AL Brault, I Erjavec, A Cipcic, I Grgurevic, ... Journal of the American Society of Nephrology 22 (4), 681-692, 2011 | 77 | 2011 |
| Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy FP Schena, VW Anelli, J Trotta, T Di Noia, C Manno, G Tripepi, G D’Arrigo, ... Kidney international 99 (5), 1179-1188, 2021 | 61 | 2021 |
| Non-diabetic renal disease in Croatian patients with type 2 diabetes mellitus I Horvatic, M Tisljar, P Kacinari, I Matesic, S Bulimbasic, DG Ljubanovic, ... Diabetes research and clinical practice 104 (3), 443-450, 2014 | 53 | 2014 |
| Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown? P Gauckler, JI Shin, F Alberici, V Audard, A Bruchfeld, M Busch, ... Autoimmunity reviews 19 (11), 102671, 2020 | 52 | 2020 |
| Rituximab in membranous nephropathy P Gauckler, JI Shin, F Alberici, V Audard, A Bruchfeld, M Busch, ... Kidney International Reports 6 (4), 881-893, 2021 | 51 | 2021 |
| Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome M Crnogorac, I Horvatic, P Kacinari, DG Ljubanovic, K Galesic Journal of Nephrology 31, 257-262, 2018 | 51 | 2018 |
| Epidemiologic data of adult native biopsy-proven renal diseases in Croatia I Horvatic, M Tisljar, S Bulimbasic, B Bozic, D Galesic Ljubanovic, ... International urology and nephrology 45, 1577-1587, 2013 | 50 | 2013 |
| Acute interstitial nephritis due to mesalazine: Case Report M Tadic, I Grgurevic, M SCUKANEC‐SPOLJAR, B Bozic, S Marusic, ... Nephrology 10 (2), 103-105, 2005 | 41 | 2005 |
| Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool SJ Barbour, M Canney, R Coppo, H Zhang, ZH Liu, Y Suzuki, K Matsuzaki, ... Kidney International 98 (4), 1009-1019, 2020 | 40 | 2020 |
| Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy SJ Barbour, R Coppo, H Zhang, ZH Liu, Y Suzuki, K Matsuzaki, L Er, ... Kidney international 102 (1), 160-172, 2022 | 34 | 2022 |
| Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy I Horvatic, DG Ljubanovic, S Bulimbasic, M Knotek, I Prkacin, M Tisljar, ... Pathology-Research and Practice 208 (11), 662-667, 2012 | 34 | 2012 |
| Treatment of renal manifestations of ANCA-associated vasculitis K Galesic, D Ljubanovic, I Horvatic Journal of nephropathology 2 (1), 6, 2013 | 32 | 2013 |
| Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy K Kiryluk, E Sanchez-Rodriguez, XJ Zhou, F Zanoni, L Liu, N Mladkova, ... Nature genetics 55 (7), 1091-1105, 2023 | 28 | 2023 |
| Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study S Moiseev, A Kronbichler, E Makarov, N Bulanov, M Crnogorac, ... Rheumatology 60 (10), 4654-4661, 2021 | 27 | 2021 |
| Minimal change disease and acute tubular necrosis caused by diclofenac K Galešić, D Ljubanović, S Bulimbašić, I Račić Nephrology 13 (1), 87-88, 2008 | 25 | 2008 |
| Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy R Coppo, L Peruzzi, E Loiacono, M Bergallo, A Krutova, ML Russo, ... Nephrology Dialysis Transplantation 34 (4), 587-596, 2019 | 22 | 2019 |
| Pleural mesothelioma and membranous nephropathy K Galesic, B Bozic, R Heinzl, M Scukanec-Spoljar, V Bozikov Nephron 84 (1), 71-74, 2000 | 21 | 2000 |
